Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 4
2010 2
2011 7
2012 5
2013 7
2014 3
2015 4
2016 6
2017 5
2018 4
2019 1
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

44 results
Results by year
Filters applied: . Clear all
Page 1
Prevalence of preclinical Alzheimer disease: Comparison of current classification systems.
Kern S, Zetterberg H, Kern J, Zettergren A, Waern M, Höglund K, Andreasson U, Wetterberg H, Börjesson-Hanson A, Blennow K, Skoog I. Kern S, et al. Among authors: borjesson hanson a. Neurology. 2018 May 8;90(19):e1682-e1691. doi: 10.1212/WNL.0000000000005476. Epub 2018 Apr 13. Neurology. 2018. PMID: 29653987 Free PMC article.
Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.
Lawlor B, Segurado R, Kennelly S, Olde Rikkert MGM, Howard R, Pasquier F, Börjesson-Hanson A, Tsolaki M, Lucca U, Molloy DW, Coen R, Riepe MW, Kálmán J, Kenny RA, Cregg F, O'Dwyer S, Walsh C, Adams J, Banzi R, Breuilh L, Daly L, Hendrix S, Aisen P, Gaynor S, Sheikhi A, Taekema DG, Verhey FR, Nemni R, Nobili F, Franceschi M, Frisoni G, Zanetti O, Konsta A, Anastasios O, Nenopoulou S, Tsolaki-Tagaraki F, Pakaski M, Dereeper O, de la Sayette V, Sénéchal O, Lavenu I, Devendeville A, Calais G, Crawford F, Mullan M; NILVAD Study Group. Lawlor B, et al. Among authors: borjesson hanson a. PLoS Med. 2018 Sep 24;15(9):e1002660. doi: 10.1371/journal.pmed.1002660. eCollection 2018 Sep. PLoS Med. 2018. PMID: 30248105 Free PMC article. Clinical Trial.
The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial.
Abdullah L, Crawford F, Tsolaki M, Börjesson-Hanson A, Olde Rikkert M, Pasquier F, Wallin A, Kennelly S, Ait-Ghezala G, Paris D, Hendrix S, Blennow K, Lawlor B, Mullan M. Abdullah L, et al. Among authors: borjesson hanson a. Front Neurol. 2020 Mar 6;11:149. doi: 10.3389/fneur.2020.00149. eCollection 2020. Front Neurol. 2020. PMID: 32210906 Free PMC article.
The Gothenburg MCI study: Design and distribution of Alzheimer's disease and subcortical vascular disease diagnoses from baseline to 6-year follow-up.
Wallin A, Nordlund A, Jonsson M, Lind K, Edman Å, Göthlin M, Stålhammar J, Eckerström M, Kern S, Börjesson-Hanson A, Carlsson M, Olsson E, Zetterberg H, Blennow K, Svensson J, Öhrfelt A, Bjerke M, Rolstad S, Eckerström C. Wallin A, et al. Among authors: borjesson hanson a. J Cereb Blood Flow Metab. 2016 Jan;36(1):114-31. doi: 10.1038/jcbfm.2015.147. J Cereb Blood Flow Metab. 2016. PMID: 26174331 Free PMC article. Review.
Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease.
Timmers M, Tesseur I, Bogert J, Zetterberg H, Blennow K, Börjesson-Hanson A, Baquero M, Boada M, Randolph C, Tritsmans L, Van Nueten L, Engelborghs S, Streffer JR. Timmers M, et al. Among authors: borjesson hanson a. Neurobiol Aging. 2019 Jul;79:131-141. doi: 10.1016/j.neurobiolaging.2019.03.016. Epub 2019 Apr 1. Neurobiol Aging. 2019. PMID: 31055223
Multi-infarct dementia of Swedish type is caused by a 3'UTR mutation of COL4A1.
Siitonen M, Börjesson-Hanson A, Pöyhönen M, Ora A, Pasanen P, Bras J, Kern S, Kern J, Andersen O, Stanescu H, Kleta R, Baumann M, Kalaria R, Kalimo H, Singleton A, Hardy J, Viitanen M, Myllykangas L, Guerreiro R. Siitonen M, et al. Among authors: borjesson hanson a. Brain. 2017 May 1;140(5):e29. doi: 10.1093/brain/awx062. Brain. 2017. PMID: 28369186 Free PMC article. No abstract available.
Diagnostic criteria influence dementia prevalence.
Wancata J, Börjesson-Hanson A, Ostling S, Sjögren K, Skoog I. Wancata J, et al. Among authors: borjesson hanson a. Am J Geriatr Psychiatry. 2007 Dec;15(12):1034-45. doi: 10.1097/JGP.0b013e31813c6b6c. Am J Geriatr Psychiatry. 2007. PMID: 18056822
Ponezumab in mild-to-moderate Alzheimer's disease: Randomized phase II PET-PIB study.
Landen JW, Andreasen N, Cronenberger CL, Schwartz PF, Börjesson-Hanson A, Östlund H, Sattler CA, Binneman B, Bednar MM. Landen JW, et al. Among authors: borjesson hanson a. Alzheimers Dement (N Y). 2017 Jun 8;3(3):393-401. doi: 10.1016/j.trci.2017.05.003. eCollection 2017 Sep. Alzheimers Dement (N Y). 2017. PMID: 29067345 Free PMC article.
44 results